Venrock Healthcare Capital Partners , L.P. Insider Profile
18 Followers
Venrock Healthcare Capital Partners , L.P., Ten Percent Owner at Adverum Biotechnologies, holds 3.75M shares in Tricida (Ticker: TCDA), holds 20.64M shares in VistaGen Therapeutics (Ticker: VTGN), holds 1.54M shares in KalVista Pharmaceuticals (Ticker: KALV). Most recently, Venrock Healthcare Capital Partners , L.P. Sold ― shares of Tricida on Oct 26, 2022 for an estimated value of 3.50M.
What was Venrock Healthcare Capital Partners , L.P.’s latest transaction?
Venrock Healthcare Capital Partners , L.P. latest transaction was an Informative Sell of $3.50M.
What was Venrock Healthcare Capital Partners , L.P.'s most profitable transaction?
Venrock Healthcare Capital Partners , L.P.’s most profitable transaction was an Informative Sell of VTGN stock on July 14, 2022. The return on the trade was 87.80%.
What is Venrock Healthcare Capital Partners , L.P.'s role in Adverum Biotechnologies?
Venrock Healthcare Capital Partners , L.P.'s role in Adverum Biotechnologies is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.